Cloud Adoption in the Life Sciences Industry
Cloud technology and its use of multi-tennant app solutions are increasing the capabilities of Life Sciences solutions and reducing IT infrastructure costs through the sharing of infrastructure and investment cross-industry.
In some areas multi-tenant cloud solutions have become ubiquitous. For example, Salesforce.com claim >150K customers utilize their platform for Customer Relationship Management. Furthermore, many routinely rely on cloud services associated with their computer backups and data services associated with cell phones.
Nonetheless, the perceptions and interpretations of the regulations by which the life sciences industry must conduct its business still leave many uncertain about whether or not they can - or should - pursue the use of cloud solutions for GxP applications.
The goal of this work stream has been to provide a practical, usable framework to overcome those barriers. Through the use of this framework, it is envisaged that the barriers to adoption by pharma of cloud-based technology will be addressed.
|Geoff Low||Working Group Lead||MDSOL||Geoff.Low@Phuse.eu|
|Tony Hewer||Project Lead||Medidataemail@example.com|
|Wendy Dobson||Project Co-ordinator||PhUSEfirstname.lastname@example.org|
Project Team Members
|Richard Martinez||Participant||RHO Worldemail@example.com|
|Pieter Stas||Participant||Business & Decision Life Sciencesfirstname.lastname@example.org|
The team has representatives from SaaS, PaaS and IaaS providers as well as "consumer organisations".
Further participation is always welcome - especially in the areas of:
- Cloud technologies & IT infrastructure
- Systems Validation & Quality Assurance
- Information Protection and IT Security
- R&D Applications Expertise
This workstream has generated value for serveral levels of stakeholder:
- For the wider audience - interested in knowing what is possible in cloud computing - it has generated use cases that illustrate the successful implementations - or pitfalls - in the use of cloud-based technology.
- For the IT professionals it has generated information materials that help to guide efforts to implement quickly, and in regulatory compliance, cloud technologies as well as providing decision trees to support technology decision making.
- For the regulatory professionals it provides a clear mapping between technology capabilities and regulatory requirements.
The third edition of the framework document has recently been created and is currently awaiting publication. It is viewable at:
The framework has reached it present state through the efforts of a core group plus the input of a great many participants since the work stream was established in 2013. Thanks, in particular are extended to contributors from FDA.
In Nov 2015, the framework was presented to members of EMA's GCP Inspector Working Group and it is expected that follow-on dialog will take place.
Further presentations on the framework, have, during 2016, been made to the Pistoia Alliance and the eClinical Forum as well as at the PhUSE Annual Conference in Barcelona and the DIA's Clinical Forum for Operational Excellence in Düsseldorf.
Last revision by Laurenwhite,01/19/2018